3Ettomger DS. Is there a preferred combination chemotherapy regimen for melastastic non-small cell lung cancer?The Oncologist,2002,7:226.
4Haffty BG,Son YH,Sasaki CT,et al. Mitomycin C as an adjunct to postoperative radiation therapy in squamous cell carcinoma of the head and neckresults from two randomized clinical trial.Int J Radiat Oncol Biol Phys , 1993,27: 241-250.
6Dobrowsky W, Naude J, Dobrowsky E, et al.Continuous hyperfractionated accelerated radiotherapy with/wthout mitomycin C in head and neck cancer. Int J Radiat Oncol Biol Phys, 1998,42:803-805.
2Goldman S. Preclinical biologyof interleukin 1 1:a multifunctional hematopoietic cytokine with potent thrombopoietic activity[J]. Stem Cells, 1995,13:462.
3Paul S,Bennett F, Calvetti J,et al.Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine [J].Prec Natl Acad Sci USA, 1999,87:7512.
4Du X X,Darid A W. Interleukin- 11:Review of molecular, cell biology, and clinical use[J]. Blood,1997,89:3897.
5Ettomger DS. Is there a preferred combination chemotherapy regimen for metastastic non-small cell lung cancer[J]. The Oncologist,2002,7: 226
6O'Reilly MS,Holmgren L,Shing Y,et al. Angiostatin:a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma [J]. Cell, 1994,79:315
7Herbst RS,Hidalgo M,Pierson AS,et al. Angiogenesis inhibitors in clinical development for lung cancer [J]. Semin Oncol,2002,29(s4) :6
8O'Reilly MS, Holmgren L, Chen C, et al. Angiostatin induces and sustains dormancy of human primary tumors in mice [J]. Nat Med, 1996,2:689
9Te Velde EA, Vogten JM, Gebbink MF, et al. Enhanced antitumour efficacy by combining conventional chemotherapy with angiostatin or endostatin in a liver metastasis model [J]. Br J Surg,2002,89(10) :1302
10Teicher BA, Holden Sa,Ara C,et al. Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other antiangiogenic agents [J]. Int J Cancer, 1994 ; 57: 920
